rivastigmine has been researched along with Hallucination of Body Sensation in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (44.44) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 3 (16.67) | 2.80 |
Authors | Studies |
---|---|
Begemann, MJH; d'Angremont, E; Sommer, IEC; van Laar, T | 1 |
Beireis, LA; Burgett, RN; Farley, TM | 1 |
Breuning, L; Dautzenberg, PLJ | 1 |
Bloem, BR; de Bie, RMA; de Haan, RJ; Foncke, EMJ; Munts, AG; Post, B; Schmand, BA; Tissingh, G; van Harten, B; van Mierlo, TJM | 1 |
Bonnet, U; Knierim, U; Stuehler, L; Taha, S | 1 |
Demirci, S; Hanoglu, L; Polat, B; Tavli, AM; Yildiz, S; Yilmaz, N; Yulug, B | 1 |
Aarsland, D; Cummings, J; Dronamraju, N; Emre, M; Lane, R; Tekin, S | 1 |
Attard, A; Jacobsen, P; Patel, SS; Shergill, S | 2 |
Bedouch, P; Besson, G; Casez, O; Chapuis, C; Lagrange, E | 1 |
Bullock, R; Cameron, A | 1 |
Retz, W; Retz-Junginger, P; Rösler, M; Supprian, T; Wobrock, T | 1 |
Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA | 1 |
Kaufer, DI | 1 |
Dautzenberg, PL; Rovers, JM; ter Bruggen, JP | 1 |
Aarsland, D; Burn, D; De Deyn, PP; Emre, M; Hsu, C; Lane, R; McKeith, I | 1 |
Cummings, JL; Emre, M; Lane, RM | 1 |
Luce, AK; McKeith, IG; Reading, PJ | 1 |
3 review(s) available for rivastigmine and Hallucination of Body Sensation
Article | Year |
---|---|
Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Female; Hallucinations; Humans; Male; Parkinson Disease; Randomized Controlled Trials as Topic; Rivastigmine | 2023 |
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.
Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Hallucinations; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
Topics: Activities of Daily Living; Alzheimer Disease; Double-Blind Method; Hallucinations; Humans; Lewy Body Disease; Mental Status Schedule; Multicenter Studies as Topic; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome | 2007 |
5 trial(s) available for rivastigmine and Hallucination of Body Sensation
Article | Year |
---|---|
Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up.
Topics: Cholinesterase Inhibitors; Follow-Up Studies; Hallucinations; Humans; Parkinson Disease; Phenylcarbamates; Rivastigmine | 2021 |
Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Analysis of Variance; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Hallucinations; Humans; Male; Mental Status Schedule; Neuroprotective Agents; Phenylcarbamates; Placebo Effect; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Humans; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Prospective Studies; Reaction Time; Risk Factors; Rivastigmine | 2004 |
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome | 2006 |
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
Topics: Aged; Carbamates; Caregivers; Cognition Disorders; Female; Follow-Up Studies; Hallucinations; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Psychotic Disorders; Rivastigmine; Stress, Psychological; Treatment Outcome | 2001 |
10 other study(ies) available for rivastigmine and Hallucination of Body Sensation
Article | Year |
---|---|
Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics.
Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Hallucinations; Humans; Lewy Body Disease; Male; Psychotic Disorders; Quetiapine Fumarate; Rivastigmine | 2019 |
[Rivastigmine as treatment for flashbacks and REM sleep problems in an older patient].
Topics: Dreams; Female; Hallucinations; Humans; Incest; Middle Aged; Panic Disorder; Rivastigmine; Sleep Wake Disorders; Sleep, REM; Treatment Outcome | 2021 |
The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Delirium; Disease Progression; Hallucinations; Humans; Male; Rivastigmine | 2019 |
Therapeutic Effects of Rivastigmine and Alfa-Lipoic Acid Combination in the Charles Bonnet Syndrome: Electroencephalography Correlates.
Topics: Aged; Antioxidants; Case-Control Studies; Cholinesterase Inhibitors; Drug Therapy, Combination; Electroencephalography; Female; Hallucinations; Humans; Male; Middle Aged; Rivastigmine; Syndrome; Thioctic Acid; Treatment Outcome; Vision Disorders | 2016 |
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Drug Resistance; Female; Hallucinations; Humans; Phenylcarbamates; Rivastigmine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.
Topics: Aged; Cholinesterase Inhibitors; Creutzfeldt-Jakob Syndrome; Female; Hallucinations; Humans; Lewy Body Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2012 |
Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Dementia; Female; Hallucinations; Humans; Male; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2002 |
[Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Topics: Affective Disorders, Psychotic; Aged; Aged, 80 and over; Alzheimer Disease; Anxiety Disorders; Carbamates; Cholinesterase Inhibitors; Cognition; Disease Progression; Female; Hallucinations; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior | 2004 |
[Rivastigmine as adjunctive therapy in the therapeutic dilemma for the treatment of hallucinations due to Parkinson disease].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Female; Hallucinations; Humans; Male; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2006 |